MKT Advisors’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
MKT Advisors's PFE Position: Q2 2026 in Review
MKT Advisors reduced its Pfizer (PFE) stake by 33% in Q2 2026, selling an estimated $140K and leaving 10,679 shares worth $257K. The position accounts for 0.08% of the portfolio, ranked #137.
MKT Advisors first reported a position in PFE in Q4 2021 and has held it in 19 quarters since. The position peaked at $1.63M in Q2 2022. 2,822 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- MKT Advisors held 10,679 shares of Pfizer worth $257K as of Q2 2026.
- MKT Advisors sold 5,336 Pfizer shares in Q2 2026, an estimated $140K.
- Pfizer made up 0.08% of MKT Advisors's portfolio in Q2 2026, its #137 holding.
- MKT Advisors first reported a position in Pfizer in Q4 2021 and has held it in 19 quarters since.
- MKT Advisors's Pfizer position peaked at $1.63M in Q2 2022.
- 2,822 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on MKT Advisors's 13F filing for Q2 2026, filed 9 Jul 2026.